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Abstract.  The o~4 integrin is a receptor involved in 
the interaction of epithelial cells with basement mem- 
branes. This integrin is unique among the known in- 
tegrins in that its t4 subunit has a large cytoplasmic 
domain, The function of this cytoplasmic domain is 
not known. In this paper we show that the/L subunit 
undergoes proteolytic processing in cultured cells and 
provide evidence that this also happens in tissues. 
Immunoprecipitation experiments indicated that the cy- 
toplasmic domain of #4 is susceptible to a calcium- 
dependent protease present in cellular extracts. In 
vitro assays with purified calpain showed that this 
enzyme can cleave ~4 at two distinct sites in the cyto- 
plasmic domain, generating truncated molecules of 
165 and 130 kD.  Immunoblotting experirnents per- 
formed on cultured epithelial cells using an antibody 
to a peptide modeled after the COOH-terminus of the 
/L subunit showed 70-kD fragments and several frag- 
ments of molecular masses between 185 and 115 kD. 
Similar fragments were detected in CHO cells trans- 
fected with the full-length/L eDNA, but not in con- 
trol transfected cells or in cells transfected with a mu- 
tant eDNA lacking the epitope of the cytoplasmic 
peptide antibody. The sizes  of the fragments indicated 
that both the intracellular and extracellular domains of 
t4 are proteolytically processed. To examine the 
processing of the/L subunit in epithelial tissues in 
vivo, human skin frozen sections were stained with 
antibodies to the ectodomain or the cytoplasmic domain 
of t4 The distinct staining patterns obtained with the 
two types of antibodies provided evidence that t4 is 
proteolyticaUy processed in vivo in skin. Analogous 
experiments performed on sections of the cornea sug- 
gested that t, is not proteolytically processed at a de- 
tectable level in this tissue. Thus,  cleavage of the t4 
subunit occurs in a tissue-specific fashion. These 
results suggest a potential mechanism of modulating 
the activities of the cx6fl4 integrin. 
T 
i  HE Ot~4 integrin is expressed by epithelial and neuro- 
epithelial cells (22). In epithelial tissues, this integrin 
is restricted to the basal portion of those cells which 
contact the basement membrane, suggesting a role in adhe- 
sion to basement membranes (4,  12, 22, 24, 25). Its ligand 
may be laminin or a laminin isoform (15, 23). The primary 
sequences of both the ct~ and the t, subunits have been re- 
cently determined (10, 27,  28).  The t, subunit  is unique 
among integrin fl subunits because of  the large size of its cy- 
toplasmic domain. This part of the molecule, which mea- 
sures over 100 kD, contains two pairs of type III fibronectin 
repeats  interrupted by a sequence which shows variations, 
probably as a result of alternative splicing of  mRNA (10, 27, 
28). Type m  fibronectin repeats are commonly found in ex- 
tracellular matrix molecules and in the external portion of 
many adhesion receptors (16). In addition to the intracyto- 
plasmic portion of f14, two other known intracellular mole- 
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cules with such repeats are twitchin and titin,  two related 
proteins of the myofibrillar cytoskeleton (1). It is possible 
that the/34 gene has originated by the junction of exons en- 
coding an ancestral integrin with exons  of a cytoskeletal 
molecule. 
The 134 subunit is identical to the so-called Tumor Specif- 
ic Protein 180 (TSP180), a molecule  whose expression is in- 
creased in invasive carcinomas relative to benign adenomas 
and normal tissues (13). The/34 subunit might therefore be 
regulated by transformation  differently from the asfl, fibro- 
nectin receptor, whose expression is decreased in fibroblasts 
transformed by viral oncogenes (17). 
To examine the function of the o~dL  integrin, we have be- 
gun gene transfer experiments.  During the initial phase of 
these studies, we observed that the f14 subunit undergoes an 
in vivo proteolytic  processing affecting both the extraceUular 
and the intracellular domains of  the molecule. This process- 
ing, which is also observed in CHO cells transfected with a 
fl~ expression construct, is specific to t4 and does not occur 
with other integrin fl subunits. 
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Peptides, Antibodies, and Cell Lines 
Peptides  ware synthesized by using  a peptide  synthesizer  (Applied  Bio- 
systems, Foster City, CA) and solid-phase t-boc chemistry. After cleavage 
and deprotection  with trifluoromethane  sulfuric  acid,  the peptides  were 
purified by reverse-phase HPLC chromatography. 
The r  subunit-specific  rabbit pulyclonal  antibody was elicited by im- 
munization  with a  29-mer synthetic  peptide  (NKKDHYDATYHKAEI- 
HAQPSDKERLTSDA) reproducing  the  COOH-terminal  29-amino-acid 
portion of the human a6 subunit (28). The ~4 subunit-specific  rabbit puly- 
clomd antibody  was raised  against the synthetic peptide  CTRHVTQEF- 
VSRTLTTSGTLSTHMDQQFFQT (3 l-mer). This paptide is modeled after 
the COOH-terminal segment of the large cytoplasmic domain of the human 
~4 subunit (10, 27). Both peptides were conjugated to keyhole limpet hemo- 
cyanin for immunization. In order to obtain peptide-specific antibodies, the 
~4 cytoplasmic peptide serum was affinity purified on a column made with 
the peptide used for immunization. To this end, the peptide was crossliaked 
to BSA at a molar ratio of 50:1 using gintaraldehyde. The BSA-peptide con- 
jugate was then covalentiy linked to CNBr-activated Sepharose. This proce- 
dure was used because it allows for efficient exposure of the peptide to the 
fluid phase of chromatography.  The a5 and B1 subunit-speciflc  cytoplas- 
mic peptide  antibodies were previously described  (6). The 3E1 mAb (9) 
recognizes the extraceihilar portion of the ~4 subunit, as demonstrated by 
staining of intact live cells. The 346.11A rat mAb to mouse/~4 (13) was 
provided by Dr. S. Kennel (Oak Ridge National  Laboratory,  Oak Ridge, 
TN). The GOH3 rat mAb to cx6 (21) was provided by Dr. A. Sonnenberg 
(Central Laboratory  of the Netherlands Red Cross and University of Am- 
sterdam,  Amsterdam,  The Netherlands). 
The SW480 human colon carcinoma cells and the A431 epidermoid car- 
cinoma cells were cultured in DME with 10% FBS. Primary human fore- 
skin  keratinocytes  were  maintained  in  serum-free  keratinocyte  growth 
medium  supplemented  with  insulin,  EGF,  hydrocortisone,  and  bovine 
pituitary  extract  (Clonetics  Corp.,  San  Diego,  CA).  The dihydrofolate 
reductase (dhfr)-negative CHO-DG44 cells (29) were grown in nucleoside- 
free ~x-modified MEM  (r  MEM)  supplemented  with  10%  FBS, 
hypoxanthine, and thymidine. Transfected CHO-DG44 cells were cultured 
in o,-minus MEM supplemented  with 10% dialyzed FBS. 
Expression Constructs and Transfection 
A full-length eDNA clone for the human ~4 subunit was assembled in the 
cytomngalovirus promoter-based expression vector pRC-CMV (Invitrogen 
Corp., San Diego, CA). The two overlapping partial clones ~4-1 (5.6 kb) 
(27) and ~4-E2 (1.6 kb),  which cover the entire coding sequence of ~4, 
were subcloned into the EcoRI site of pBSKII+, generating the plasmids 
pBSK-1 and pBSK-E2. The 0.9-kb HindlII-XbaI fragment of pBSK-E2 was 
then ligated in pRC-CMV. The resulting plasmid was digested with BspM2 
and XhaI and ligated to the 4.9-kb BspM2-XbaI fragment of pBSK-1. The 
resulting  expression  construct,  encoding  a  full-length  B4  subunit,  was 
designated pCMV-/~4. An expression vector encoding a truncated  tailless 
B4 subunit  was created from pCMV-B, by engineering  a  stop  codon  at 
amino acid position 855. The pCMV-O4 vector was digested with AccI and, 
after partial filling in with C+T, cut with BspE1. The resulting 6.2-kb frag- 
ment was ligated to the L9-kb BspEI-AccI fragment of pCMV-B4. The pro- 
cedure of adjoining the AccI end at position 2687 with the partially filled 
XbaI end generated  a stop codon at amino acid position 855. Correctness 
of this construct,  termed pCMV-/~dxcyto, was verified by sequencing. Se- 
quencing was performed by the dideoxy chain termination method using Se- 
quenase (United States Biochemical Corp., Cleveland, OH). The restric- 
tion enzymes were from New England Biolabs (Beverly, MA), Stratagene 
(La Jolla, CA), and  Boehringer  Mannheim  Biochemicals  (Indianapolis, 
IN).  T4  DNA ligase, calf intestinal  phosphatase,  the large  fragment  of 
Klenow polymerase,  and  nucleotides  were from  Boehringer  Mannheim 
Biochemicals. 
CHO-DG44 cells were transfected  with  10/~g  of either  pCMV-/~4 or 
pCMV-~4Acyto. Cotransfection of 1 #g of pSV2-dhfr (26) provided the se- 
lection marker.  The dhfr-positive  cells were selected  in nucleoside-free 
medium and pooled.  Clones with high level expression of the transfected 
B4 molecules  were selected  by three cycles of fluorescence-activated cell 
sorting with the anti-human/34 3El mAb. Clonal cell lines were then ob- 
tained by limiting dilution. 
Control cell lines were generated by transfection of pSV2-dhfr alone and 
subsequent selection in nucleoside-free medium. Two independent control 
clones,  C1 and C5, the pCMV-B4 transfected clone B10, and the pCMV- 
B4Acyto transfected clone D2 were used throughout this study. 
Immunoprecipitation A nalyses 
For immunoprecipitation,  cells were labeled in suspension with 125I by the 
lactoperoxidase-H202  method  as previously described  (18) or metaboli- 
cally labeled with 50 ~tCi/mi of [3SS]methionine (>800 Ci/mmol; New En- 
gland Nuclear)  for 6 h. After washing, the cells were extracted with lysis 
buffer containing 0.5 % Triton X-100, 50 mM 'l~is (pH 7,5), 150 mM NaCI, 
0.01% aprotinin (Sigma Chemical Co., St. Louis, MO), 4 ~tg/mi pepstatin 
A (Sigma Chemical Co.),  10/~g/mi leupeptin (Sigma Chemical Co.), and 
either 1 mM CaCI2 or 10 mM ethylenediaminetetrnacetate  (EDTA). For 
experiments of in vitro cleavage of r  by calpain, the protease inhihitors 
in the lysis buffer were replaced with 10 mM EDTA, or 20 ~tM CaC12, or 
20 ~M CaCI2 and I00 ~tM N-acetyl-leucyl-leucyl-norleucinal  (Calpain In- 
hibitor I; Boehringer Mannheim Biochemicals). Immunoprecipitation anal- 
yses were performed as previously described (6). Cycles of immunodeple- 
tion were also as previously described  (6).  All the immunoprecipitations 
were analyzed by SDS-PAGE (14) and autoradiography  with X-Omat AR 
films (Eastman Kodak Co., Rochester, NY). 
In Vitro Digestion with Calpain 
To obtain radiolabeled intact B4 subunit, the u6B4 integrin was immunopre- 
cipitated from [35S]methionine-labeled SW480 cells. The extraction buffer 
consisted of  0.5 % Triton X-100, 50 mM Tris (pH 7.5), 150 mM NaCI, 0.01% 
aprotinin  (Sigma Chemical  Co.), 4/~g/ml pepstatin  A (Sigma Chemical 
Co.),  10 ~tg/ml leupeptin (Sigma Chemical Co.),  10 mM EDTA, and 100 
/~M Calpain Inhibitor L The sample was precipitated with the 3El mAb and 
Sepharose-conjugated anti-mouse IgG. The Sepharnse-bound material was 
washed with lysis buffer without protease fnhibitors and equilibrated in cal- 
pain digestion buffer (10 mM Tris, pH 7.5, 25 mM NaC1, 1 mM CaC12). 
The Sepharose suspension was then divided into 50-/~1 aliquots. Each ali- 
quot was incubated  with the indicated  concentrations  of purified  80-kD 
catalytic subunit of calpain (from rabbit skeletal muscle; Sigma Chemical 
Co.) for 15 rain at room temperature.  The samples were boiled in SDS- 
PAGE sample buffer and analyzed by SDS-PAGE and autoradiography. 
Immunoblotting 
Confluent cell monolayers were extracted at 95~  with SDS-PAGE sample 
buffer supplemented with 10 mM EDTA. Samples containing  100/~g total 
proteins were separated by SDS-PAGE and subjected to immunoblotting ac- 
cording to previously published procedures (6). The afffinity-purified  cyto- 
plasmic peptide antibodies  were used at 5 ~g/ml.  Competitive inhibition 
was effected by incubation of the peptide antibodies (5 ~tg/mi) with excess 
of the corresponding  peptide  (100 /,g/ml).  Specificity controls were ob- 
tained by incubating the/34 cytoplasmic peptide antibodies (5/~g/ml) with 
a/3t cytoplasmic peptide  (100 btg/ml). 
Immunohistochemistry 
Human skin biopsies,  mouse skin samples, and human corneas,  obtained 
from the National Direct Research Interchange  (Philadelphia,  PA), were 
frozen and embedded in OCT medium. Cryostat sections of 6/~m thickness 
were fixed with 3.7% paraformaldehyde in PBS or left unfixed. In some ex- 
periments,  the paraformaldehyde-fixed tissue sections were perme~btlized 
with 0.5%  Triton X-IO0 in PBS before fixation.  Staining was performed 
using the hybridoma culture supernatants  undiluted, the ascites diluted at 
1:1,000, and the affinity-purified cytoplasmic peptide antibodies at 5/~g/ml. 
Peptide competitions were done as described for immunoblotting. After in- 
cubation  with the primary  antibodies,  the sections  were incubated  with 
biotinylated secondary antibodies followed by a preformed avidin-biotinyl- 
ated HRP complex  (Vectastain ABC; Vector Laboratories,  Burlingame, 
CA), with FITC-conjugated donkey anti-rabbit  IgG or with TRITC-conju- 
gated donkey anti-mouse IgG. 
Results 
Calcium-dependent Proteolysis of  B4 
To examine the expression of the c~4 integrin at the sur- 
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tion of c~6/34 from metabolic- 
ally  labeled  or  surface-iodi- 
hated  SW480 cells.  SW480 
cells were labeled either by a 
6-h incubation with  [35S]me- 
thionine (lanes a and b), or at 
the cell surface with ~25I (lane 
c). After extraction in a deter- 
gent buffer containing 10 mM 
EDTA and other inhibitors of 
calcium-activated  proteases, 
the samples were immunopre- 
cipitated with normal mouse 
immunoglobulins (lane a) or 
with the 3El antibody (lanes b 
and c). The samples were then 
analyzed by SDS-PAGE  under 
nonreducing conditions. 
Figure 1. Surface labeling and immunoprecipitation of c~6~4 from 
SW480 cells in the presence or absence of calcium. SW480 cells 
were labeled at the cell surface with ~2~I and extracted in a deter- 
gent buffer containing 10 mM EDTA  (lanes a and c), or 1 mM calci- 
um (lanes b and d). After immunoprecipitation with the 3El mAb, 
the samples were analyzed by SDS-PAGE  under reducing (R) and 
nonreducing (NR) conditions. 
face of epithelial cells, we performed immunoprecipitation 
experiments with the mAb 3El that recognizes the extracel- 
lular  portion of the  ~4  subunit.  SW480  colon carcinoma 
cells were iodinated at the cell surface and extracted in the 
presence of calcium or EDTA. In addition to the or6 and/34 
subunits,  the  3El  antibody precipitated two  polypeptides 
with apparent molecular masses of 165 and 130 kD (Fig. 1). 
Comparing immunoprecipitates from calcium- and EDTA- 
containing extracts showed that the abundance of the 165- 
and 130-kD polypeptides relative to the 200-kD ~/4 subunit 
was higher in extracts containing calcium (Fig.  1, compare 
lanes a and b, and c and d). These results suggested that the 
~4 subunit can be cleaved in vitro, presumably as a result of 
a  calcium-dependent  process.  In  agreement  with  our 
findings,  previous  results  have  demonstrated  ~4-related 
polypeptides of molecular masses  similar to the  165- and 
130-kD molecules described here (8). In our experiments, 
EDTA did not prevent completely the appearance of these 
proteolytic fragments (Fig.  1, lanes a  and c). We hypothe- 
sized that the fragments detected in EDTA extracts could 
reflect an in vivo physiological processing of the ~4 subunit. 
To confirm and extend these results, we performed immu- 
noprecipitation experiments with cells labeled either meta- 
bolically with  [35S]methionine  or at the cell  surface with 
t25I. SW480 cells were extracted in a  detergent buffer in- 
cluding EDTA and other inhibitors of calcium-activated pro- 
teases. As shown in Fig. 2, only a6 and the intact form of 
/~4 could be detected in metabolically labeled cells, indicat- 
ing that the ~4 subunit is stable during the initial stages of 
its biosynthesis and that our extraction conditions effectively 
prevent its in vitro proteolysis (Fig. 2, lane b). In contrast, 
the 165- and 130-kD proteolytic products of/~, could be de- 
tected in  immunoprecipitates from surface-iodinated cells 
extracted and processed under identical conditions (Fig. 2, 
lane c).  We therefore concluded that a  fraction of the ~4 
molecules expressed in culture by SW480 cells undergoes 
proteolytic cleavage. As shown below, products of the pro- 
teolytic processing can also be detected in intact cells with- 
out iodination. 
Cleavage of the Cytoplasmic Domain of  ~  by Calpain 
We next set out to determine whether the/~4 subunit was 
susceptible to proteolytic cleavage by one of the isoforms of 
the calcium-activated enzyme calpain. SW480 cells were la- 
beled  metabolically  with  psS]methionine  and  then  ex- 
tracted under different conditions: in the absence of calcium, 
in the presence of 20 /~M calcium,  or in the presence of 
calcium  and  the  synthetic  peptide  inhibitor  of  calpain, 
N-acetyl-leucyl-leucyl-norleucinal. The extracts  were  im- 
munoprecipitated either with the mAb 3El or with affinity- 
purified antibodies to a synthetic peptide modeled after the 
COOH-terminal 31-amino acid segment of the cytoplasmic 
domain of/~, (Fig.  3 A).  The experiment showed that mi- 
cromolar amounts of calcium are sufficient to activate the 
proteolytic activity present in cellular extracts (Fig. 3, com- 
pare lanes a and c) and that this calcium-dependent proteoly- 
sis is effectively inhibited by the peptide inhibitor of calpain 
(Fig. 3, compare lanes c and e). The results suggested that 
/~4 can be proteolytically cleaved in vitro by the type I iso- 
form of calpain. Since the 165- and 130-kD proteolytic frag- 
ments of/~4 were not recognized by the cytoplasmic pep- 
tide antibodies (Fig. 3, lane d), we concluded that they were 
the result of cleavage within the cytoplasmic portion of the 
molecule. 
To investigate directly the susceptibility of the/34 subunit 
to  calpain,  we  incubated the  immunoisolated  intact  c~6/~4 
integrin with different amounts of the purified enzyme. The 
experiment showed that calpain is able to cleave ~/4 in a dose- 
dependent way generating fragments of molecular weights Figure 3. In vitro cleavage of 
the #4 subunit by calpaln.  (,4) 
SW480 cells were labeled for 
6 h with [35S]methionine and 
extracted in the presence of lO 
mM EDTA, or 20/~M calci- 
urn, or 20 t~M calcium and a 
peptide  inhibitor  of calpaln. 
The samples were then immu- 
noprecipitated  with  the  3El 
mAb (lanes a, c, and e), or the 
~4  cytoplasmic  peptide  anti- 
serum  (lanes  b,  d,  and f). 
SDS-PAGE was under nonre- 
ducing conditions. (B) SW480 
cells  were  labeled  6  h  with 
pSS]methionine. Alter extrac- 
tion in presence of 10 mM EDTA and other inhibitors of calcium-activated proteases, the material was immunoprecipitated  with the 3El 
antibody and Sepharose-conjugated  anti-mouse IgG. The Sepharose-bound precipitated  material was equilibrated  in calpain digestion 
buffer and divided into two aliquots. The aliquots were incubated for 15 min at room temperature  with calpaln (+, 6 #g/ml) or without 
it (-) and then analyzed by SDS-PAGE under nonreducing conditions. 
similar to that of those generated in cellular extracts (Fig. 3 
B).  The pattern of digestion of the #,  subunit induced by 
calpain was not entirely identical to that observed upon addi- 
tion of calcium to cellular extracts, perhaps because in the 
former assay the substrate was purified, while in the latter 
it was not.  However, the calpain-generated fragments were 
similar to the fragments seen in the cell extracts in that they 
also could not be precipitated with the cytoplasmic peptide 
antibody (not shown). These results show that the cytoplas- 
mic domain of B4 can be cleaved by calpain and  that the 
resulting fragments are similar to the endogenous cleavage 
products. 
Proteolytic Digestion of  [34 in Cultured Cells 
To extend the analysis of the proteolytic processing of B4, 
we performed immunoblotting experiments on extracts of 
various epithelial cell lines. Cell monolayers were extracted 
in SDS-PAGE sample buffer at 95~  to prevent posflytic in 
vitro degradation. After electrophoresis and blotting, the ex- 
tracts were probed with afffinity-purified  antibodies to the cy- 
toplasmic  peptide  of B,  (Fig.  4).  The  antibodies  reacted 
with two different sets of bands: a  doublet at '~70 kD and 
several other bands with molecular masses between 185 and 
115 kD (Fig. 4 A). The reaction was specific, because it was 
Figure 4. Immunoblotting of 
B4  fragments  in  epithelial  cell 
lines.  SW480 colon  carcino- 
ma  cells  (lane  a),  primary  hu- 
man keratinocytes  (lane  b), 
and  A431 epidermoid  carci- 
noma cells  (lane c) were  ex- 
tracted in SDS-PAGE sample 
buffer at 95~  Samples con- 
taining  150 #g of total pro- 
teins were separated by SDS- 
PAGE under nonreducing con- 
ditions and transferred to nitro- 
cellulose. Identical filters were 
probed  with  affinity-purified 
antibodies to the  COOH-ter- 
minal peptide of/~4, in the ab- 
sence (.4) or in the presence of 
the peptide used for the immu- 
nization  to  produce  the  an- 
tipeptide serum (B), and with 
affinity-purified antibodies  to 
the  cytoplasmic  peptide  of 
~  (C). Figure 5. (A) Cell surface ex- 
pression  of  recombinant  t4 
molecules. CHO clones trans- 
fected  with  the  selection 
marker  plasmid alone  (C1), 
the  fitll-length  f14  eDNA 
(BIO), or the cytoplasmic de- 
letion mutant t4 eDNA (D2) 
were iodinated at the cell sur- 
face. After extraction in a de- 
tergent  buffer  containing  EDTA 
and other protease inhibitors, 
samples containing the same 
amount  of TCA-precipitable 
radioactivity  were immuno- 
precipitated with the c~6 cyto- 
plasmic  peptide  antibody 
(tx6), or the f14 mAb 3El (/34). 
The  unprecipitated  material 
of the 3El  sample was sub- 
jected to three additional cy- 
cles  of immunoprecipitation 
with the same antibody. The 
residual  material  was  then 
precipitated with the -6 cyto- 
plasmic  peptide  antibody 
(B4"*c~6). (B)  Synthesis rate 
of  endogenous and  recom- 
binant integrin subunits in the CHO clones. CHO clones transfected with the selection marker plasmid alone (C5) or the full-length t4 
eDNA (B/0) were metabolically labeled by a 10-rain pulse of [35S]rnethionine, then immediately extracted and immunoprecipitated with 
cytoplasmic peptide antibodies to the ~5, a6, ill, and t4 subunits. 
inhibited by the peptide used for immunization (Fig. 4 B), 
but not by an irrelevant peptide. A faint 35-kD band was ob- 
served  in  some  immunoblotting experiments.  Under  the 
same conditions and with similar cytoplasmic peptide anti- 
bodies, we could not detect any proteolytic fragment of the 
fll (Fig. 4  C) or t3 subunit.  The 70-kD fragments have a 
size compatible with their being generated by the intracellu- 
lax  proteolytic activity of calpain.  The  larger  fragments, 
however,  can only originate from the digestion of the ex- 
tracellular portion of the molecule. The results collectively 
indicated that in cell culture a  subset of t4 molecules un- 
dergoes a complex pattern of  proteolytic degradation involv- 
ing possibly calpain, but also extracellular proteases. 
We next analyzed/L processing in CHO cell lines ex- 
pressing recombinant t4 molecules from eDNA. The CHO 
cells, which, as shown below,  express an endogenous old~ 
complex and no/L, were transfected with the expression 
construct pCMV-fl4 encoding the full-length t4 subunit, or 
with the plasmid pCMV-fl4Acyto  encoding a  truncated f14 
snbtmit lacking most of the cytoplasmic domain.  Clones 
with high-level expression of the recombinant subunits were 
selected by FACS and further analyzed by surface iodination 
and immunoprecipitation. Fig.  5  A  shows the results ob- 
tained with representative clones.  C1,  a  clone transfected 
with the selection marker plasmid alone, similarly to the pa- 
rental cells, expressed an endogenous otd~l integrin, but no 
/L subunit. B10, a clone transfected with the full-length fl~ 
eDNA, expressed an c~r  complex recognized by both the 
3El mAb and a cytoplasmic peptide antiserum to ot~. The 
recombinant human t4  subunit therefore associated  with 
the endogenous ot~ subunit and it was correctly exported to 
the cell surface. D2,  a clone transfected with the plasmid 
pCMV-fl4Acyto,  expressed at the cell surface a complex of 
ao with the 95-kD truncated t4 subunit. Thus, the truncated 
t4 subunit was also correctly expressed at the cell surface. 
Immunodepletion experiments showed that expression of 
the fl~ subunit in association with or6 was greatly reduced in 
the clones expressing recombinant t4 molecules (Fig. 5 A). 
The reduction of otd~l was proportional to the level of ex- 
pression of the transfected t4 eDNA in different clones (not 
shown).  These  results  suggest that the  or6  subunit has  a 
higher affinity for  t4  than  for  fl~. To  address  this  point 
directly, we examined the transfected cells for the synthesis 
rate of fl~, f14, and the two main a  subunits expressed by 
CHO cells, a~ and or6. As shown in Fig. 5 B, clone B10 syn- 
thesizes the recombinant t4 subunit at a rate lower than that 
of the endogenous ill. The same clone expresses at the cell 
surface high levels of the o~dL integrin, but the amount of 
otaffl is reduced relative to the control clone. We conclude 
therefore that or6  combines more  efficiently with t4  than 
with ill. 
The experiments of surface iodination and immunoprecip- 
itation shown in Fig. 5 A suggested that the recombinant/3, 
subunit expressed in CHO cells undergoes a proteolytic pro- 
cessing similar to that of the endogenous t4 molecule in ep- 
ithelial cells. To examine this question, control clones and 
clones transfected with the full-length or the truncated ~4 
eDNA were extracted in SDS-PAGE sample buffer at 95~ 
and subjected to immunoblotting (Fig. 6). In cells expressing 
the full-length f14 eDNA, the f14 cytoplasmic peptide anti- 
bodies  reacted  with the  intact recombinant t4  molecule, 
with a number of high molecular mass fragments, and with 
a doublet at ',,70 kD (Fig. 6, A, lane b). No polypeptide was 
recognized by these antibodies in extracts of control cells 
Giancotti et al. Proteolysis of fl~ Integrin Subunit  955 Figure 6. Immunoblotting  of 8, fragments in CHO cells express- 
ing recombinant 8, molecules. The CHO clones Ct, transfeeted 
with the selection marker plasmid alone (a), BIO, expressing the 
full-length 84 eDNA (b),  and D2,  expressing the truncated 84 
eDNA that lacks the epitope of the 84 cytoplasmic peptide anti- 
bodies (c), were extracted in SDS-PAGE sample buffer at 95~ 
Samples containing 150 #g of total proteins were separated by 
SDS-PAGE under nonreducing conditions and transferred to nitro- 
cellulose. Identical filters were probed with affinity-pudfied anti- 
bodies to the COOH-terminal peptide of 84, in the absence (A) or 
in the presence of the peptide used for immunization (B), and with 
affinity-purified  antibodies to the cytoplasmic peptide of 8t (C). 
(Fig. 6 A, lane a) or of cells transfected with the truncated 
/3, cDNA (Fig. 6 A, lane c). In addition, the reaction with 
the recombinant/3, molecule and its fragments in cells ex- 
pressing the full-length eDNA was inhibited by the peptide 
that had been used as the immunogen (Fig. 6 B), but not by 
an irrelevant peptide. In the same experiment we could not 
detect any proteolysis of the Bt subunit (Fig. 6  C). The ~, 
subunit therefore undergoes proteolytic processing in cell 
lines with endogenous/34, as well as in CHO cells trans- 
fected with the full-length B, eDNA. 
Immunohistochemical  Detection of  B~ and 
Its Proteolytic Fragments 
To  determine  whether  the  B4  subunit  is  proteolytically 
processed in tissues in vivo, frozen sections of human skin 
were stained with the 3El mAb to the ectodomain of B, and 
with the affinity-purified peptide antibodies to the COOH- 
terminal segment of the cytoplasmic domain of/3,- In ac- 
cordance with previous results (9), the 3El antibody reacted 
exclusively with the basal surface of cells of the germinative 
layer (Fig. 7 A). A similar staining pattern was obtained with 
the anti-cx~ mAb GOH3, and with the B, mAb 346-11A on 
mouse skin sections (not shown; see also refs. 4, 23, 24). The 
COOH-terminal peptide antibodies generated a different  pat- 
tern. The reaction was restricted to the cells of the germina- 
rive layer, but extended to their cytoplasms (Fig. 7 B). The 
staining was inhibited by the corresponding peptide, but not 
by an irrelevant one. It is unlikely that the linear staining pat- 
tern generated by the 3El mAb is due to a limited accessibil- 
ity of  its epitope on the lateral and apical surfaces of  the basal 
cells, because an identical pattern was obtained with anti- 
bodies (3El,  GOH3, 346-11A) recognizing epitopes in the 
ectodomain of both the ~x6 and B4  subunits and by using 
different fixation and permeabilization procedures.  More- 
over,  published studies show that antibodies to the or2 and 
a3  subunits stain all surfaces of the basal layer kerarino- 
cytes, indicating access of antibodies to every aspect of  these 
cells (see, e.g., ref. 2).  The data therefore suggest that B, 
molecules bearing the COOH-terminal epitope of the pep- 
tide antibody, but lacking the extracellular epitope of  the 3El 
antibody, exist within the cytoplasm of basal keratinocytes. 
Therefore, these results suggest that the proteolyric process- 
ing of B4 observed in cultured cells also occurs in vivo in 
the skin. 
We next compared another stratified squamous epithe- 
lium, the cornea, to the skin. In the cornea, both the 3El 
mAbs and the COOH-terminal peptide antibody generated 
an identical basement membrane-like staining pattern (Fig. 
8). Some staining was seen around the corneal cells in the 
upper layers, but this was also similar for both types of anti- 
bodies. These results suggest that proteolysis of B4 does not 
occur in the cornea. Thus, cleavage of/34 may be regulated 
in vivo in a tissue-specific fashion. 
Discussion 
We show that the f34 subunit undergoes a complex proteo- 
lyric processing affecting both the extracellular and intracel- 
lular domains of the molecule. The ~84 integrin is struc- 
turally different from other integrins because of the large 
cytoplasmic domain of the/34 subunit (10, 27). In stratified 
squamous epithelia, including skin, tongue, and cornea, the 
receptor is concentrated within the hemidesmosomes (11, 
24,  25).  Thus,  in contrast to other integrins, ,~,  is not 
likely to connect to the actin filament system. Instead, it may 
interact, directly or indirectly, with the keratin filament sys- 
tem. Such an interaction may contribute to the maintenance 
of cell surface polarity and to the stability of the epithelial 
sheet. In the stratified squamous epithelia, the receptor is ex- 
pressed exclusively by the cells of the basal layer (2, 4,  12, 
24).  Thus, expression of c~,  is rapidly turned off at the 
onset of cell differentiation and movement to the upper cell 
layers (7). 
Our immunoblotting experiments with cytoplasmic pep- 
ride  antibodies  revealed  two  sets  of/3,  fragments:  there 
were several fragments with sizes between 185 and 115 kD, 
and two fragments of ,~70 kD. The sizes, immunoreacrivi- 
ties, and heterogeneity of the larger fragments suggest that 
they are products of  one or more extracellular proteases. The 
two 70-kD fragments, which represent large segments from 
the cytoplasmic domain of/~,, may be produced as a result 
of digestion by one of the isoforms of the calcium-activated 
protease calpain. We found that the cleavage of the B, cyto- 
plasmic  domain  in  cell  extracts  was  due  to  a  calcium- 
activated proteolyric activity and that the cleavage could be 
blocked by a specific peptide inhibitor of calpain. Further- 
more, purified calpain cleaved the cytoplasmic segment of 
~, at two places.  One of the cleavage regions is ,'070 kD 
from the COOH-terminus of  the polypeptide, because a 130- 
kD fragment lacking the COOH-terminal antigenic deter- 
minant was generated. In agreement with the existence of 
such a cleavage, we detected two 70-kD fragments that were 
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/34 molecules  in the skin.  Frozen  sections 
of human  skin were fixed,  permeabilized 
with acetone, and stained with the/34 mAb 
(A), or with the affinity-purified antibodies 
to the  COOH-terminal  peptide  of ~4  (B) 
followed by biotinylated secondary antibod- 
ies  and  a  preformed  avidin-biotinylated 
HRP  complex.  Counterstaining  was  ef- 
fected with hematoxylin.  Note that the cy- 
toplasms, but not the nuclei, of basal cells, 
are stained by the COOH-terminal  peptide 
antibodies. 
recognized  in  immunoblotting  by the cytoplasmic peptide 
antibody. These fragments differ only slightly in size, possi- 
bly reflecting  the  existence of two closely spaced  calpain 
cleavage sites. 
Inspection of the amino acid sequence of the cytoplasmic 
domain of/3, reveals several potential cleavage sites for cal- 
pain.  Cleavage  at  either  R1289-E1290  or  R1355-S1356 
would generate fragments of 130 and 70 kD, while cleavage 
at R1529-V1530 would give 165- and 35-kD fragments. Mol- 
ecules susceptible to proteolysis by calpain generally contain 
at least one region enriched in proline (P), glutamic acid (E), 
aspartic acid (D),  serine (S), and threonine  (T) (PEST re- 
gion) (30). Such regions, which are typically located at some 
distance from the cleavage site, are thought to be able to bind 
calcium ions and facilitate the interaction of the enzyme with 
its substrate. We have searched the amino acid sequence of 
/~4 for PEST regions  with the PC/GENE  protein sequence 
analysis software. We found that at least two such regions are 
present  in  the  cytoplasmic  domain  of/3~  (position  1685- 
1696 with  PEST score of -0.15,  and position  1554-1592 
with PEST score of -1.6). 
Our results show that a portion of the total 8, in cultured 
cells is comprised of molecules that apparently lack a large 
segment of the extraceUular domain.  The portion lacking in 
these fragments includes the region that is thought to con- 
tribute to the ligand binding site (5). In addition, the promi- 
nence  of the  70-kD  fragments  that  include  the  COOH- 
terminus of/34 suggests that a portion of/34 molecules both 
in vitro and in vivo lacks a major part of the cytoplasmic do- 
main.  Proteolytic cleavage of 84 could therefore alter both 
the ligand binding activity and the cytoskeletal connections 
of ~,. 
We have also analyzed CHO clones expressing human 84 
subunits from cDNA. The results indicated that a fraction of 
the recombinant/34  subunit expressed by these cells under- 
goes a proteolytic processing similar to that observed with 
cultured epithelial cells. The gene transfer experiments also 
established  that the ~6 subunit has a higher  affinity for 84 
than  for B1. This  latter finding  provides a  molecular basis 
for previous observations indicating that, in cells expressing 
o~6, ~,  and 84 subunits,  o~d34 generally  predominates  over 
that of otd3, (4,  15, 23, 25). 
Giancotti et al. Proteolysis of t~4 Integrin Subunit  957 Figure 8.  Immunofluorescence localization of/34 in the skin and in the cornea. Unfixed frozen sections of human skin (A and B) or human 
cornea (C and D) were subjected to double labeling with the/34 mAb and the affinity-purified antibodies to the COOH-terminal peptide 
of ~4. TRITC-conjugated anti-mouse IgG and FITC-conjugated anti-rabbit IgG were used to detect, respectively, the bound monoclonal 
(A and C) and rabbit peptide antibodies (B and D). In the skin, the staining at the basement membrane appears more intense than in the 
cornea. The basal aspect of the basal cell membrane in skin is undulating and thus appears thicker than a similar region of the basal cells 
of the corneal epithelium which is fiat. Note that the COOH-terminal peptide antibodies intensely stain the cytoplasm of the basal cells 
of the skin (B) but not of the cornea (D). 
While only a fraction of 84 molecules underwent proteo- 
lyric processing in the cultured cells, the immunohistochem- 
istry results suggest that in vivo in the skin a larger fraction 
of the/34 molecules is proteolytically processed.  In fact, 
staining of skin epithelium showed that the COOH-terminal 
cytoplasmic domain epitope was homogeneously  distributed 
in the cytoplasm, while the ectodomain epitope was selec- 
tively localized at the basal cell surface. These data suggest 
that factors operating in vivo in the skin contribute to an ac- 
celerated rate of processing of ~4 in this tissue. 
It is possible that proteolysis of this basement membrane 
receptor  is  related  to  the  remodeling  of  adhesive  and 
cytoskeletal structures which occurs in the skin, when the 
basal cells detach from the basement membrane at the onset 
of differentiation. This interpretation is consistent with the 
apparent lack of/~4 processing in the cornea, another strat- 
ified epithelium. In contrast to those of skin, the stem cells 
of cornea reside in the limbus, a transitional zone between 
the epithelium and the conjunctiva, and differentiate while 
moving centripetally along the basement membrane (3, 20). 
Thus, differentiating corneal keratinocytes maintain a more 
prolonged interaction with the basement membrane. Further 
experiments will be needed to examine this hypothesis. Taken 
together, our results indicate that the ad~4 receptor, unlike 
other integrins, undergoes regulated proteolytic  processing 
in vivo. 
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